{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T15:58:53Z","timestamp":1791561533623,"version":"4.3.4"},"reference-count":32,"publisher":"American Medical Association (AMA)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Neurol"],"published-print":{"date-parts":[[2025,10,1]]},"abstract":"<jats:sec>\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Epilepsy affects approximately 65 million people worldwide, and 60% have focal seizures. Predicting seizure response and drug resistance to antiseizure medications (ASMs) in people with focal epilepsy remains difficult.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To describe the expected short- and long-term response to treatment with ASMs in people with focal epilepsy using recognized definitions by the International League Against Epilepsy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>The Human Epilepsy Project is an international, prospective, observational cohort study that followed up people with newly diagnosed focal epilepsy for up to 6 years between 2012 and 2020. Data were analyzed from 2023 to 2024. The Human Epilepsy Project was conducted at 34 tertiary epilepsy centers across the US, Australia, and Europe. Participants with confirmed diagnosis of focal epilepsy aged 12 to 60 years were enrolled within 4 months of treatment initiation with ASM(s). Data were analyzed from February 2024 to July 2024.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Exposure<\/jats:title>\n                    <jats:p>ASM (variable).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>The primary outcome was seizure freedom, defined as a period without seizures for 12 months or 3 times the longest pretreatment seizure-free interval, whichever was longer. Treatment response was categorized as sensitive, meaning seizure free receiving 2 or fewer adequate ASM trials; resistant, meaning having 2 or more adequate ASM trials fail; or indeterminate (neither treatment sensitive nor resistant).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among 448 enrolled participants, 267 (59.6%) were female, and median (IQR) participant age was 32 (21-44) years at treatment initiation. Median (IQR) follow-up duration was 3.13 (2.33-3.55) years. Most achieved seizure freedom (267 participants of 448 [59.6%]), largely without relapse (223 [83.5%]). There were 245 treatment-sensitive participants (54.7%), 102 treatment-resistant participants (22.8%), and 101 indeterminate participants (22.5%). Among treatment-sensitive participants, most (217 [89.3%]) responded to monotherapy and half (121 [49.4%], or 27% of total cohort) became seizure free while receiving their first ASM. In the first year of treatment, 251 participants (63%) had ongoing or worsening seizures. Median time to first seizure freedom was 12.1 months (95% CI, 9.7-16.1). This occurred earlier in those who never relapsed (median, 2.2 months; 95% CI, 0.8-3.2) than those who did (median, 7.4 months; 95% CI, 4.0-10.7). Those with infrequent pretreatment seizures were 0.30-fold less likely to be treatment resistant than those with very frequent seizures (hazard ratio, 0.30; 95% CI, 0.14-0.64;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009.002; Holm-Bonferroni\u2013corrected\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009.006). Participants with self-reported comorbid psychological disorders were 1.78-fold more likely to be treatment resistant than those without (relative risk, 1.78; 95% CI, 1.26-2.52;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>In the Human Epilepsy Project multicenter prospective cohort study, most people with newly diagnosed focal epilepsy took more than a year and more than 1 ASM to become seizure free. Drug resistance can be identified earlier in those with frequent pretreatment seizures, and a history of psychiatric comorbidities at epilepsy diagnosis is an important prognostic factor.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial Registration<\/jats:title>\n                    <jats:p>\n                      ClinicalTrials.gov Identifier:\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.clinicaltrials.gov\/study\/NCT02126774?cond=NCT02126774&amp;amp;amp;rank=1\">NCT02126774<\/jats:ext-link>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamaneurol.2025.2949","type":"journal-article","created":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T15:30:56Z","timestamp":1756135856000},"page":"1022","source":"Crossref","is-referenced-by-count":21,"title":["Treatment Response to Antiseizure Medications in People With Newly Diagnosed Focal Epilepsy"],"prefix":"10.1001","volume":"82","author":[{"given":"Sarah N.","family":"Barnard","sequence":"first","affiliation":[{"name":"School of Translational Medicine, Monash University, Melbourne, Victoria, Australia"},{"name":"Alfred Health, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhibin","family":"Chen","sequence":"additional","affiliation":[{"name":"School of Translational Medicine, Monash University, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manisha","family":"Holmes","sequence":"additional","affiliation":[{"name":"Westchester Medical Center Health Network, New York Medical College, Valhalla"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres M.","family":"Kanner","sequence":"additional","affiliation":[{"name":"Miller School of Medicine, University of Miami, Miami, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manu","family":"Hegde","sequence":"additional","affiliation":[{"name":"University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruben","family":"Kuzniecky","sequence":"additional","affiliation":[{"name":"Northwell Health, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Lowenstein","sequence":"additional","affiliation":[{"name":"University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline A.","family":"French","sequence":"additional","affiliation":[{"name":"Grossman School of Medicine, New York University, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Human Epilepsy Project (1) Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Boro","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project (1) Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres","family":"Kanner","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project (1) Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Cole","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project (1) Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andy","family":"Rodriguez","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project (1) Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry","family":"Gidal","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project (1) Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bassel","family":"Abou-Khalil","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project (1) Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandy","family":"Fureman","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project (1) Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Alldredge","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project (1) Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Neuray","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project (1) Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Szabo","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project (1) Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Morrison","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project (1) Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dale","family":"Hesdorffer","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project (1) Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Lowenstein","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project (1) Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Ficker","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project (1) Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Gloss","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project (1) Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"Dlugos","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project (1) Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Faught","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project (1) Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Schmid","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project (1) Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Geller","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project (1) Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernest","family":"Somerville","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project (1) Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugen","family":"Trinka","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project (1) Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Cutter","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project (1) Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graeme","family":"Jackson","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project (1) Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Cascino","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project (1) Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Krauss","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project (1) Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Worrell","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project (1) Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamada","family":"Hamid","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project (1) Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heath","family":"Pardoe","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project (1) Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"French","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project (1) Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Cloyd","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project (1) Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerzy","family":"Szaflarski","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project (1) Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Barry","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project (1) Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Hixson","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project (1) Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Pollard","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project (1) Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Halford","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project (1) Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joon","family":"Kang","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project (1) Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Burneo","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project (1) Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judy","family":"Weisenberg","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project (1) Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamil","family":"Detyniecki","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project (1) Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimford","family":"Meador","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project (1) Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen","family":"Park","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project (1) Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara","family":"Marcuse","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project (1) Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Lin","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project (1) Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Brandon","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project (1) Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeline","family":"Fields","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project (1) Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mangala","family":"Nadkarni","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project (1) Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manisha","family":"Holmes","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project (1) Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manu","family":"Hegde","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project (1) Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarita","family":"Kirschner","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project (1) Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Bebin","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project (1) Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melodie","family":"Winawer","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project (1) Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Gelfand","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project (1) Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Sperling","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project (1) Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Jette","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project (1) Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omotola","family":"Hope","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project (1) Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orrin","family":"Devinsky","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project (1) Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Penovich","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project (1) Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Kwan","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project (1) Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Atkinson","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project (1) Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavel","family":"Klein","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project (1) Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Widdess-Walsh","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project (1) Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rani","family":"Singh","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project (1) Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reeta","family":"K\u00e4lvi\u00e4inen","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project (1) Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Knowlton","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project (1) Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruben","family":"Kuzniecky","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project (1) Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Barnard","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project (1) Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Mintzer","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project (1) Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheryl","family":"Haut","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project (1) Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siddhartha","family":"Nadkarni","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project (1) Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Glynn","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project (1) Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Herman","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project (1) Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terence","family":"O\u2019Brien","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project (1) Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy","family":"Glauser","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project (1) Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tricia","family":"Ting","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project (1) Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"3","key":"noi250055r1","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1212\/WNL.0000000000003509","article-title":"Prevalence and incidence of epilepsy: a systematic review and meta-analysis of international studies.","volume":"88","author":"Fiest","year":"2017","journal-title":"Neurology"},{"issue":"1","key":"noi250055r2","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/epi.13604","article-title":"The burden of premature mortality of epilepsy in high-income countries: a systematic review from the Mortality Task Force of the International League Against Epilepsy.","volume":"58","author":"Thurman","year":"2017","journal-title":"Epilepsia"},{"issue":"4","key":"noi250055r3","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S1474-4422(18)30454-X","article-title":"Global, regional, and national burden of epilepsy, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.","volume":"18","author":"Beghi","year":"2019","journal-title":"Lancet Neurol"},{"issue":"9","key":"noi250055r4","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.2589","article-title":"The burden of epilepsy and unmet need in people with focal seizures.","volume":"12","author":"Ioannou","year":"2022","journal-title":"Brain Behav"},{"issue":"3","key":"noi250055r5","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1001\/jamaneurol.2017.3949","article-title":"Treatment outcomes in patients with newly diagnosed epilepsy treated with established and new antiepileptic drugs a 30-year longitudinal cohort study.","volume":"75","author":"Chen","year":"2018","journal-title":"JAMA Neurol"},{"issue":"5","key":"noi250055r6","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1056\/NEJM200002033420503","article-title":"Early identification of refractory epilepsy.","volume":"342","author":"Kwan","year":"2000","journal-title":"N Engl J Med"},{"issue":"20","key":"noi250055r7","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1212\/WNL.0b013e3182563b19","article-title":"Patterns of treatment response in newly diagnosed epilepsy.","volume":"78","author":"Brodie","year":"2012","journal-title":"Neurology"},{"issue":"6","key":"noi250055r8","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1111\/j.1528-1167.2009.02397.x","article-title":"Definition of drug resistant epilepsy: consensus proposal by the ad hoc task force of the ILAE Commission on Therapeutic Strategies.","volume":"51","author":"Kwan","year":"2010","journal-title":"Epilepsia"},{"issue":"12","key":"noi250055r10","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.1111\/epi.16707","article-title":"Focal nonmotor versus motor seizures: the impact on diagnostic delay in focal epilepsy.","volume":"61","author":"Pellinen","year":"2020","journal-title":"Epilepsia"},{"issue":"4","key":"noi250055r11","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1007\/s10309-018-0216-8","article-title":"Operational classification of seizure types by the International League Against Epilepsy: position paper of the ILAE Commission for Classification and Terminology.","volume":"31","author":"Fisher","year":"2018","journal-title":"Zeitschrift f\u00fcr Epileptologie"},{"issue":"12","key":"noi250055r12","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1002\/acn3.50950","article-title":"Investigation of patient and observer agreement on description of seizures at initial clinical visit.","volume":"6","author":"Saleem","year":"2019","journal-title":"Ann Clin Transl Neurol"},{"issue":"6","key":"noi250055r13","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1001\/jama.2018.21554","article-title":"Using the E-value to assess the potential effect of unmeasured confounding in observational studies.","volume":"321","author":"Haneuse","year":"2019","journal-title":"JAMA"},{"issue":"8","key":"noi250055r14","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/S1474-4422(23)00151-5","article-title":"Drug resistance in epilepsy.","volume":"22","author":"Perucca","year":"2023","journal-title":"Lancet Neurol"},{"issue":"75","key":"noi250055r15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta25750","article-title":"Lamotrigine versus levetiracetam or zonisamide for focal epilepsy and valproate versus levetiracetam for generalised and unclassified epilepsy: two SANAD II non-inferiority RCTs.","volume":"25","author":"Marson","year":"2021","journal-title":"Health Technol Assess"},{"issue":"2","key":"noi250055r16","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000209500","article-title":"Trends in antiseizure medication initiation, switch, or termination in patients with newly diagnosed epilepsy: a nationwide study.","volume":"103","author":"Bolin","year":"2024","journal-title":"Neurology"},{"issue":"7","key":"noi250055r17","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1111\/epi.13781","article-title":"Concurrent mood and anxiety disorders are associated with pharmacoresistant seizures in patients with MTLE.","volume":"58","author":"Nogueira","year":"2017","journal-title":"Epilepsia"},{"key":"noi250055r18","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.seizure.2017.04.007","article-title":"Psychiatric comorbidities in new onset epilepsy: should they be always investigated?","volume":"49","author":"Kanner","year":"2017","journal-title":"Seizure"},{"issue":"8","key":"noi250055r19","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.1212\/WNL.58.8_suppl_5.S27","article-title":"Depression and epilepsy: how closely related are they?","volume":"58","author":"Kanner","year":"2002","journal-title":"Neurology"},{"issue":"6","key":"noi250055r20","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1111\/j.1528-1167.2012.03488.x","article-title":"Depressive and anxiety disorders in epilepsy: do they differ in their potential to worsen common antiepileptic drug-related adverse events?","volume":"53","author":"Kanner","year":"2012","journal-title":"Epilepsia"},{"issue":"2","key":"noi250055r22","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1002\/ana.23601","article-title":"Epilepsy, suicidality, and psychiatric disorders: a bidirectional association.","volume":"72","author":"Hesdorffer","year":"2012","journal-title":"Ann Neurol"},{"issue":"5","key":"noi250055r23","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1111\/j.1600-0404.2011.01488.x","article-title":"Self-reported symptoms in patients on antiepileptic drugs in monotherapy.","volume":"124","author":"Wieshmann","year":"2011","journal-title":"Acta Neurol Scand"},{"key":"noi250055r24","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.yebeh.2015.03.018","article-title":"Self-reported aggressiveness during treatment with levetiracetam correlates with depression.","volume":"45","author":"Mula","year":"2015","journal-title":"Epilepsy Behav"},{"issue":"7","key":"noi250055r25","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000209821","article-title":"The adverse effects of commonly prescribed antiseizure medications in adults with newly diagnosed focal epilepsy.","volume":"103","author":"Barnard","year":"2024","journal-title":"Neurology"},{"issue":"3","key":"noi250055r26","first-page":"177","article-title":"The impact of anti-seizure medications on psychiatric disorders among children with epilepsy: both a challenge and an opportunity?","volume":"32","author":"Datta","year":"2023","journal-title":"J Can Acad Child Adolesc Psychiatry"},{"issue":"5","key":"noi250055r27","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1001\/jamaneurol.2020.0032","article-title":"Tolerability of antiseizure medications in individuals with newly diagnosed epilepsy.","volume":"77","author":"Alsfouk","year":"2020","journal-title":"JAMA Neurol"},{"issue":"111","key":"noi250055r28","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1016\/j.yebeh.2020.107199","article-title":"Factors related to the adverse events of antiepileptic drugs.","volume":"2020","author":"Siarava","year":"2017","journal-title":"Epilepsy Behav"},{"key":"noi250055r29","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2021.107989","article-title":"Pediatric adverse reactions to antiseizure medications - an analysis of data from the Italian spontaneous reporting system (2001-2019).","volume":"119","author":"Franco","year":"2021","journal-title":"Epilepsy Behav"},{"issue":"3","key":"noi250055r30","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1111\/j.1528-1167.2006.00956.x","article-title":"The Liverpool Adverse Events Profile: relation to AED use and mood.","volume":"48","author":"Panelli","year":"2007","journal-title":"Epilepsia"},{"issue":"2","key":"noi250055r31","doi-asserted-by":"publisher","first-page":"74","DOI":"10.14581\/jer.18012","article-title":"Validity of the Liverpool Adverse Events Profile as a screening tool for detecting comorbid depression or anxiety disorder in people with epilepsy.","volume":"8","author":"Kwon","year":"2018","journal-title":"J Epilepsy Res"},{"issue":"3","key":"noi250055r32","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1212\/WNL.0b013e318207b073","article-title":"Adverse antiepileptic drug effects in new-onset seizures: a case-control study.","volume":"76","author":"Perucca","year":"2011","journal-title":"Neurology"},{"key":"noi250055r21","first-page":"1","volume-title":"Psychiatric Issues in Epilepsy: A Practical Guide to Diagnosis and Treatment","author":"Ettinger","year":"2006"},{"key":"noi250055r9","unstructured":"The Human Epilepsy Project. Accessed October 20, 2023. http:\/\/www.humanepilepsyproject.org"}],"container-title":["JAMA Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/articlepdf\/2838122\/jamaneurology_barnard_2025_oi_250055_1758903873.91448.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T15:01:43Z","timestamp":1760367703000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/fullarticle\/2838122"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,1]]},"references-count":32,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaneurol.2025.2949","relation":{},"ISSN":["2168-6149"],"issn-type":[{"value":"2168-6149","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,1]]}}}